Binding of arachidonic acid and two flavonoid inhibitors to human 12- and 15-lipoxygenases: A steered molecular dynamics study

Journal of Molecular Modeling

Volumn 16, Issue 5, 2010, Pages 1039-1045

  Mascayano, Carolina ^a   Núñez, Gabriel ^a   Acevedo, Waldo ^a   Rezende, Marcos Caroli ^a  

^a UNIVERSIDAD DE SANTIAGO DE CHILE   (Chile)

Author keywords

Arachidonic acid; Baicalein; Lipoxygenases; Quercetin; Steered molecular dynamics

Indexed keywords

ARACHIDONATE 12 LIPOXYGENASE; ARACHIDONATE 15 LIPOXYGENASE; ARACHIDONIC ACID; BAICALEIN; FLAVONOID; QUERCETIN; ISOPROTEIN; LIPOXYGENASE;

ARTICLE; BINDING SITE; CHEMICAL STRUCTURE; COMPETITIVE INHIBITION; DRUG BINDING; HUMAN; MOLECULAR DOCKING; MOLECULAR DYNAMICS; PRIORITY JOURNAL; CHEMISTRY; DRUG ANTAGONISM; GENETICS; METABOLISM;

ARACHIDONATE 15-LIPOXYGENASE; ARACHIDONIC ACID; FLAVONOIDS; HUMANS; LIPOXYGENASE; MOLECULAR DYNAMICS SIMULATION; PROTEIN ISOFORMS; QUERCETIN;

EID: 77953920595     PISSN: 16102940     EISSN: 09485023     Source Type: Journal    
DOI: 10.1007/s00894-009-0616-9     Document Type: Article

References (24)

1. Steele VE, Holmes CA, Hawk ET, Kopelovich L, Lubet RA, Crowell JA, Sigman CC, Kelloff GJ (1999) Lipoxygenase inhibitors as potential cancer chemopreventives. Cancer Epidemiol Biomark Prev 8:467-483.
2. Ylä-Herttuala S, Rosenfeld ME, Parthasarathy S, Sigal E, Särkioja T, Witztum JL, Steinberg D (1991) Gene expression in macrophage-rich human atherosclerotic lesions.15-Lipoxygenase and acetyl low density lipoprotein receptor messenger RNA colocalize with oxidation specific lipid-protein adducts. J Clin Invest 87:1146-1152.
3. Chu S, Tang L, Watney E, Chi EY, Henderson WR Jr (2000) In situ amplification of 5-Lipoxygenase and 5-Lipoxygenaseactivating protein in allergic airway inflammation and inhibition by leukotriene blockade. J Immunol 165:4640-4648.
4. Ikai K (1999) Psoriasis and the arachidonic acid cascade. J Dermatol Sci 21:135-146.
5. Shen L, Shen J, Jiang H (2003) Steered molecular dynamic simulation on the binding of NNRTI to HIV-1 RT. Biophys J 84:3547-3563.
6. Vasquez-Martinez Y, Ohri RV, Kenyon V, Holman TR, Sepúlveda-Boza S (2007) Structure-activity relationship studies of flavonoids as potent inhibitors of human platelet 12-hLO, reticulocyte 15-hLO-1, and prostate epithelial 15-hLO-2. Bioorg Med Chem 15:7408-7425.
7. Sadik CD, Sies H, Schewe T (2003) Inhibition of 15-lipoxygenases by flavonoids: structure-activity relations and mode of action. Biochem Pharmacol 65:773-781.
8. http://www.ncbi.nlm.nih.gov/pubmed/.
9. Sali A, Blundell TL (1993) Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 234:779-815.
10. Choi J, Chong JK, Kim S, Shin W (2007) Conformational flexibility in mammalian 15 S-lipoxygenase: reinterpretation of the crystallographic data. Proteins 70:1023-1032.
11. Kale L, Skeel R, Bhandarkar M, Brunner R, Gursoy A, Krawetz N, Phillips J, Shinozaki A, Varadarajan K, Schulten K (1999) J Comput Phys 151:283-312.
12. Laskowski RA, MacArthur MW, Moss DS, Thornton JM (1993) PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Cryst 26:283-291.
13. Sippl MJ (1993) Recognition of errors in three-dimensional structures of proteins. Proteins 17:355-362.
14. Melo F, Devos D, Depiereux E, Feytmans E (1997) ANOLEA: a www server to assess protein structures. Intell Syst Mol Bio 91:110-113.
15. Programs InsightII (1998) User Guide. Accelrys, San Diego.
16. Pigache A, Cieplak P, Dupradeau FY (2004) Automatic and highly reproducible RESP and ESP charge derivation: Application to the development of programs RED and X RED. 227th ACS National Meeting, Anaheim, CA, USA.
17. Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, Olson AJ (1998) Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem 19:1639-1662.
18. Brooks BR, Bruccoleri RE, Olafson BD, States DJ, Swaminathan S, Karplus M (1983) CHARMM: a program for macromolecular energy, minimization, and dynamics calculations. J Comput Chem 4:187-217.
19. Humphrey W, Dalke A, Schulten K (1996) VMD - Visual Molecular Dynamics. J Mol Graphics 14:33-38.
20. Wecksler AT, Kenyon V, Deschamps JD, Holman TR (2009) Substrate specificity changes for human reticulocyte and epithelial 15-lipoxygenases reveal allosteric product regulation. Biochemistry 28:7364-7375.
21. Park S, Shulten K (2004) Calculating potentials of mean force fron steered molecular dynamics simulations. J Chem Phys 120:5946-5961.
22. Wecksler AT, Jacquot C, Van der Donk WA, Holman TR (2009) Mechanistic investigations of human reticulocyte 15- and platelet 12-lipoxygenasees with arachidonic acid. Biochemistry 48:6259-6267.
23. Deschamps JD, Kenyon VA, Holman TR (2006) Baicalein is a potent in vitro inhibitor against both reticulocyte 15-human and platelet 12-human lipoxygenase. Bioorg Med Chem 14:4295-4301.
24. Fiorucci S, Golebiowski J, Cabrol-Bass D, Antonczak S (2008) Molecular simulations enlighten the binding mode of quercetin to lipoxygenase-3. Proteins 73:290-298.